ResMed| U.S., Canada and Latin America revenue
U.S., Canada and Latin America revenue at ResMed| came to $818.7M for the quarter to 31 Mar 2026, up 9.3% from a year earlier.
As ResMed| reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 1 May 2026.
By quarter
| Period ending | U.S., Canada and Latin America revenue | Change on a year | Filed |
|---|---|---|---|
| 31 Mar 2026 | $818.7M | up 9.3% | 1 May 2026 |
| 31 Dec 2025 | $835.0M | up 11.5% | 30 Jan 2026 |
| 30 Sep 2025 | $774.8M | up 9.5% | 31 Oct 2025 |
| 31 Mar 2025 | $749.3M | up 9.0% | 24 Apr 2025 |
| 31 Dec 2024 | $748.9M | up 11.9% | 31 Jan 2025 |
| 30 Sep 2024 | $707.3M | up 10.8% | 25 Oct 2024 |
| 31 Mar 2024 | $687.5M | up 9.3% | 26 Apr 2024 |
| 31 Dec 2023 | $669.3M | up 8.8% | 25 Jan 2024 |
| 30 Sep 2023 | $638.4M | up 10.4% | 27 Oct 2023 |
| 31 Mar 2023 | $629.1M | up 32.3% | 28 Apr 2023 |
| 31 Dec 2022 | $615.3M | up 26.4% | 27 Jan 2023 |
| 30 Sep 2022 | $578.1M | — | 28 Oct 2022 |
| 31 Mar 2022 | $475.4M | — | 29 Apr 2022 |
| 31 Dec 2021 | $486.8M | — | 28 Jan 2022 |
Definition
Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.
Other operating KPIs of ResMed|: Devices revenue · Masks and other revenue · Residential Care Software revenue · United States revenue · Rest of the World revenue · Global revenue · Combined Europe, Asia and other markets revenue · financial statements
Every KPI and segment of RMD, in the terminal.
Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.
